First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
about
Immune mechanisms in malaria: new insights in vaccine developmentSystems immunology of human malariaFerrocene-based antimalarialsA review of malaria vaccine clinical projects based on the WHO rainbow tableNovel approaches to identify protective malaria vaccine candidatesUse of massively parallel pyrosequencing to evaluate the diversity of and selection on Plasmodium falciparum csp T-cell epitopes in Lilongwe, MalawiHemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesisMolecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug ProductionSugar activation and glycosylation in PlasmodiumBeyond empiricism: informing vaccine development through innate immunity researchMalaria in school-age children in Africa: an increasingly important challengeThe case for a typhoid vaccine probe study and overview of design elementsMalaria vaccine: a future hope to curtail the global malaria burdenDrug repurposing and human parasitic protozoan diseasesRole of cytochrome P450s in insecticide resistance: impact on the control of mosquito-borne diseases and use of insecticides on EarthVaccines against invasive Salmonella disease: current status and future directionsVaccines for the 21st centuryMechanisms of cellular invasion by intracellular parasitesTransition-state inhibitors of purine salvage and other prospective enzyme targets in malariaImmune response to vaccine adjuvants during the first year of lifeVaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policyProtective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite proteinAttention to local health burden and the global disparity of health researchThe evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudiShape change in the receptor for gliding motility in Plasmodium sporozoitesStructural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175Unexpected fold in the circumsporozoite protein target of malaria vaccinesAntimalarial drug discovery - approaches and progress towards new medicines.Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infectionBiosynthesis of GDP-fucose and other sugar nucleotides in the blood stages of Plasmodium falciparumInhibitor of cysteine proteases is critical for motility and infectivity of Plasmodium sporozoitesDelivering vaccines to the people who need them mostThe March Toward Malaria VaccinesMalaria vaccine based on self-assembling protein nanoparticlesImmunogenicity of self-associated aggregates and chemically cross-linked conjugates of the 42 kDa Plasmodium falciparum merozoite surface protein-1Agrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas diseaseEfficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sitesComputational design of protein-based inhibitors of Plasmodium vivax subtilisin-like 1 proteaseA Method for Producing Protein Nanoparticles with Applications in VaccinesProduction, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation
P2860
Q21032484-0E6C127E-6899-48DE-9925-D0C2A21FE8FEQ21032488-5C5593DF-354A-4B2D-A998-B4F972D33F27Q21032535-F68DF77E-1ECE-445E-B297-E42243005715Q21034112-F79A0CFC-6E10-4A17-9EE7-FD01A76CA07DQ21131082-8038BC6C-6887-4F91-A3C6-D8FF120F3BAAQ24617275-F643D16F-8575-4E16-B7AD-B57EB3A0551DQ24810377-284BAEC9-CC72-4E4F-A84A-4E498CD1CF82Q26752273-DA590324-04A7-49B4-B84B-F1601F1DFE22Q26777652-248F1711-4E8A-41A9-92A3-20C73C6F8B08Q26824573-52B7E84E-5B30-49D9-8B48-E8B2E5F7D216Q26858829-B606263F-B35F-4170-9484-E5A1F249B582Q26859432-92F362D1-F664-40B6-AB31-F4E516DC03F0Q26996425-B78B0230-89BA-45FD-BD05-5FE184B4368DQ26999453-E7261558-B49F-4D08-89F6-E676914C5EC1Q27003964-966AB239-36E4-4F7D-968E-143BD6802675Q27007088-F534F6C4-B20A-4043-B0E1-173D170B8C35Q27007529-9185DF22-8E1B-4F21-ACE6-45EC174DEAC8Q27010243-3D0B4F2E-B8CD-4E9C-9319-CB947388A6A2Q27014881-FFE03B94-319E-4299-A1F9-3ED8F00E4581Q27016633-00A3DC4C-5E8B-4D42-A62A-1B1E53A46A90Q27022146-3A6A6102-CB4C-4637-B6E0-45F8DE416190Q27310086-2D38D3F6-D78B-4455-9C62-A5C717046513Q27318719-C297156E-77FE-45F8-A9D6-FB8979AD3C50Q27318798-0364C2AC-11F9-4A71-A2EA-5674EADA2B3CQ27675475-0047FA24-DC98-4185-9DD0-FC6E66E94FCCQ27678372-381AFC32-5DF2-4298-8AAE-29166A2C6231Q27678840-92E71815-75EA-4645-B116-BE43F274951DQ27693245-4B92AE14-0ECF-404D-9071-1860521FE024Q27972579-19B19A6C-EA0F-40EF-B4BA-8A4421435371Q27973031-BF0D5DEC-7E6B-47A9-861B-BEAC290C668BQ27974412-F77C3B5D-27F3-447E-A812-4BF9D1B4E890Q28082744-FD6DDF7F-6BDD-409E-A5A6-A0022C4330F7Q28084325-4F22C1CD-33CE-410F-ADC2-FC2BC0405DEDQ28268609-0F41BEBF-F414-4608-B1B4-B8D11958AFC6Q28484081-BAD44655-E073-4E83-A98A-EB7285F5DEAAQ28484975-FC63025B-C334-4A8C-AA02-1CAFD4E00749Q28541281-AAC0FFF8-CAAB-4F56-85C8-6974AF77D5C2Q28544098-192A6EDA-8B7C-4BF4-ACD3-ED861C8BA0E8Q28550575-0C639E0C-4DEE-4F10-BEB6-63ECF11337B6Q28554439-D8FB1982-F58D-4FB0-AC8C-589152AA0AFD
P2860
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
@en
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
@nl
type
label
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
@en
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
@nl
prefLabel
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
@en
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
@nl
P2093
P50
P356
P1476
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
@en
P2093
Afiya Radford
Agnes Akoth Onyango
Albans Msika
Alex Agyekum
Ali Mohammed Ali
Ali Said Hamad
Allan Jumbe
Allan Otieno
Ally Olotu
P304
P356
10.1056/NEJMOA1102287
P407
P50
P577
2011-10-18T00:00:00Z